Open Access

ARTICLE

2025 Chinese Expert Consensus on Clinical Applications of Biodegradable Patent Foramen Ovale Occluders

Caojin Zhang^1,#, Haibo Hu^2,#, Gangcheng Zhang^3,#, Qiguang Wang⁴, Xiaobin Chen⁵, Yingzhang Cheng⁶, Qunshan Shen⁷, Jie Yuan⁸, Wenqi Zhang⁹, Yuanshi Li¹⁰, Xuan Zheng³, Xiangbin Pan^2,*, Professional Committee of National Quality Management and Control Center for Structural Heart Diseases, Professional Committee of Structural Heart Diseases of the National Cardiovascular Disease Expert Committee

1 Guangdong Cardiovascular Institute, Guangdong Provincial People’s Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, 510080, China
2 Center of Structural Heart Disease, Chinese Academy of Medical Science, Fuwai Hospital, Peking Union Medical College, National Center of Cardiovascular Disease, Beijing, 100037, China
3 Center of Structural Heart Disease, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China
4 Department of Congenital Heart Disease, General Hospital of the Northern Theater Command, Shenyang, 110840, China
5 Department of Cardiology, Xiangya Hospital of Central South University, Changsha, 410008, China
6 Department of Cardiology, The Second Affiliated Hospital of Nanchang University, Nanchang, 330008, China
7 Cardiac Surgery Department, Wuhan Asia Heart Hospital, Wuhan, 430022, China
8 Department of Cardiology, Shenzhen People’s Hospital (First Affiliated Hospital of Southern University of Science and Technology, Second Clinical Medical College of Jinan University), Guangzhou, 518020, China
9 Department of Cardiology, China-Japan Union Hospital of Jilin University, Changchun, 130033, China
10 Department of Cardiology, the Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310009, China

* Corresponding Author: Xiangbin Pan. Email:
# These authors contributed equally to this work

Congenital Heart Disease 2025, 20(4), 403-420. https://doi.org/10.32604/chd.2025.071050

Received 30 July 2025; Accepted 29 August 2025; Issue published 18 September 2025

Abstract

Compared with traditional nickel-titanium alloy patent foramen ovale occluders, which are widely used in clinical practice, biodegradable patent foramen ovale occluders have obvious differences in material characteristics, interventional operation mode and postoperative management strategy. This article gives expert consensus on the selection of clinical indications and standardized operating procedures, so as to standardize the clinical application of biodegradable patent foramen ovale occluders.

---

Keywords

---